Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,404 | 564 | 357 | N/A | N/A |
| Receivables | N/A | 8 | 1 | N/A | N/A |
| TOTAL | $160,278 | $822 | $382 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,085 | 69 | 4 | N/A | N/A |
| Other Non-Current Assets | 543 | 194 | 0 | 0 | 0 |
| TOTAL | $1,628 | $263 | $4 | $N/A | $N/A |
| Total Assets | $161,906 | $1,085 | $386 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 951 | 769 | 522 | 0 | 0 |
| Accrued Expenses | 3,707 | 393 | 317 | N/A | N/A |
| TOTAL | $5,471 | $1,162 | $839 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 813 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 133 | 544 | 0 | 0 |
| TOTAL | $6,952 | $141 | $544 | $N/A | $N/A |
| Total Liabilities | $12,423 | $1,303 | $1,383 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,522 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | N/A | N/A | N/A | N/A |
| Retained earnings | -36,715 | -8,869 | -3,593 | N/A | N/A |
| Other shareholders' equity | 10 | 8,019 | 2,479 | 0 | 0 |
| TOTAL | $149,483 | $-218 | $-997 | $N/A | $N/A |
| Total Liabilities And Equity | $161,906 | $1,085 | $386 | $0 | $0 |